Search research articles
Contact Us
Filters
Showing results (791-800 of 827) with videos related to
Page
of 83
Sort By:
Leukemia
|
July 6, 2026
Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II
Hannah C Beird, Sankaranarayanan Kannan, Jingjing Liu, et al.
Genome Medicine
|
September 29, 2018
T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency
Erik L Clarke, A Jesse Connell, Emmanuelle Six, et al.
JCO Oncology Practice
|
July 16, 2024
Outcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis
Fadi G Haddad, Koji Sasaki, Jayastu Senapati, et al.
American Journal of Hematology
|
June 19, 2023
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation
Alexandre Bazinet, Hagop Kantarjian, Naszrin Arani, et al.
Hemasphere
|
February 16, 2026
Outcomes of therapy-related non-core binding factor acute myeloid leukemia with venetoclax-based therapies
Jayastu Senapati, Jennifer Croden, Guillermo Garcia-Manero, et al.
Blood Cancer Journal
|
June 29, 2023
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis
Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, et al.
Cancer
|
August 9, 2025
Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3-tyrosine kinase domain mutations: Prognostic implications of NPM1 co-mutation
Sankalp Arora, Wei-Ying Jen, Musa Yilmaz, et al.
Blood
|
March 31, 2025
Efficacy of a Novel BCL-xL Degrader, DT2216, in Preclinical Models of JAK2-mutated Post-MPN AML
Zhe Wang, Anna Skwarska, Gowri Poigaialwar, et al.
Blood
|
April 3, 2025
Blood-Based Proteomic Profiling Identifies OSMR as a Novel Biomarker of AML Outcomes
Patrick K Reville, Bofei Wang, Jennifer Marvin-Peek, et al.
Journal of Hematology & Oncology
|
November 28, 2025
A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias
Jayastu Senapati, Marina Konopleva, Ghayas C Issa, et al.
Page
of 83
Search research articles
Search
Showing results (791-800 of 827) with videos related to
Sort By:
Page
of 83
Leukemia
|
July 6, 2026
Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II
Hannah C Beird, Sankaranarayanan Kannan, Jingjing Liu, et al.
Genome Medicine
|
September 29, 2018
T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency
Erik L Clarke, A Jesse Connell, Emmanuelle Six, et al.
JCO Oncology Practice
|
July 16, 2024
Outcomes of Patients With Newly Diagnosed AML and Hyperleukocytosis
Fadi G Haddad, Koji Sasaki, Jayastu Senapati, et al.
American Journal of Hematology
|
June 19, 2023
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation
Alexandre Bazinet, Hagop Kantarjian, Naszrin Arani, et al.
Hemasphere
|
February 16, 2026
Outcomes of therapy-related non-core binding factor acute myeloid leukemia with venetoclax-based therapies
Jayastu Senapati, Jennifer Croden, Guillermo Garcia-Manero, et al.
Blood Cancer Journal
|
June 29, 2023
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis
Jayastu Senapati, Muharrem Muftuoglu, Jo Ishizawa, et al.
Cancer
|
August 9, 2025
Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3-tyrosine kinase domain mutations: Prognostic implications of NPM1 co-mutation
Sankalp Arora, Wei-Ying Jen, Musa Yilmaz, et al.
Blood
|
March 31, 2025
Efficacy of a Novel BCL-xL Degrader, DT2216, in Preclinical Models of JAK2-mutated Post-MPN AML
Zhe Wang, Anna Skwarska, Gowri Poigaialwar, et al.
Blood
|
April 3, 2025
Blood-Based Proteomic Profiling Identifies OSMR as a Novel Biomarker of AML Outcomes
Patrick K Reville, Bofei Wang, Jennifer Marvin-Peek, et al.
Journal of Hematology & Oncology
|
November 28, 2025
A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias
Jayastu Senapati, Marina Konopleva, Ghayas C Issa, et al.
Page
of 83